| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 219.06M | — |
| Operating expense | — | — |
| Net income | -58.37M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, SUPN returned +2.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -7.7% |
| 1 year | +2.2% |
| 5 years | +66.5% |
| 10 years | +114.5% |
| All-time high | $59.85 (Jun 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in SUPN would be worth today ›No. Supernus Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Supernus Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol SUPN.
Supernus Pharmaceuticals, Inc. is part of the Healthcare sector.
Supernus Pharmaceuticals, Inc. has a market cap of 2.67B USD, based on the latest quote.
Supernus Pharmaceuticals, Inc. is expected to report earnings around Nov 3, 2026. That date is an estimate and has not been confirmed by the company.
